Medication adherence and quality of life among Nigerian outpatients with schizophrenia.
about
Demographic and clinical correlates of sexual dysfunction among Nigerian male outpatients on conventional antipsychotic medications.Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers.Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.The knowledge and attitudes of psychiatrists towards antipsychotic long-acting injections in Nigeria.Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness.Medication Adherence Among Nigerians with Schizophrenia: Correlation Between Clinico-Demographic Factors and Quality of Life.Better quality of life in patients offered financial incentives for taking anti-psychotic medication: Linked to improved adherence or more money?Prevalence and correlates of major depression among Nigerian adults with sickle cell disease.Patterns of Prescription of Psychotropic Medications and Their Adherence among Patients with Schizophrenia in Two Psychiatric Hospitals in Accra, Ghana: A Cross-Sectional Survey.Medication-related risk factors associated with health-related quality of life among community-dwelling elderly in China.Economic burden of the therapeutic management of mental illnesses and its effect on household purchasing power
P2860
Q34296077-D4EF1238-A010-4472-B605-080B751E1FE7Q34774899-DEF8CC2E-544F-4B2D-BCE9-078398348B75Q35100117-492F2E5E-A8E8-423B-864C-0EE2C070FFF2Q36035382-3A865BBC-5286-4669-B8C8-EE3B38099650Q37079053-42D4C495-43C1-4F6B-A2B5-8F109468C8B6Q37236148-B4648B74-89DC-45D1-A593-9376CDF7D62DQ37691609-C062683F-3898-42E4-A024-99D9AC884C5BQ37736530-5E753999-FF3A-4BBA-BE56-9333289F12DFQ40019621-602E985E-3877-4C03-A257-511BDA4D6646Q47851939-DBA500BF-2087-4DFB-8228-6BA0CAC3380FQ53434932-76B50B53-F2E8-47FE-9A82-EA1AEB3365CCQ55222823-FCD43FEC-F0C8-4690-BC9F-9EF35458CE6DQ58756508-27774540-8394-40D1-9180-A58C1DD022A5
P2860
Medication adherence and quality of life among Nigerian outpatients with schizophrenia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Medication adherence and quality of life among Nigerian outpatients with schizophrenia.
@en
Medication adherence and quality of life among Nigerian outpatients with schizophrenia.
@nl
type
label
Medication adherence and quality of life among Nigerian outpatients with schizophrenia.
@en
Medication adherence and quality of life among Nigerian outpatients with schizophrenia.
@nl
prefLabel
Medication adherence and quality of life among Nigerian outpatients with schizophrenia.
@en
Medication adherence and quality of life among Nigerian outpatients with schizophrenia.
@nl
P2093
P921
P1476
Medication adherence and quality of life among Nigerian outpatients with schizophrenia.
@en
P2093
Adegoke Oloruntoba Adelufosi
Julianah Temilola Mosanya
Olukayode Abayomi
Timothy Olaolu Adebowale
P356
10.1016/J.GENHOSPPSYCH.2011.09.001
P577
2011-10-28T00:00:00Z